A 15-year trial suggests that routine prostate cancer screening may cause more harm than good due to false positives and subsequent invasive treatments. References are made to public figures like Warren Buffett who have expressed skepticism toward such screenings. The discussion links the cultural reliance on the PSA test to the widespread adoption of COVID-19 testing protocols.
